Literature DB >> 10843538

Development of Kaposi's sarcoma despite sustained suppression of HIV plasma viremia.

J Chan, S Kravcik, J B Angel.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10843538     DOI： 10.1097/00126334-199910010-00017

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  8 in total

Review 1.  Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Authors:  Aggrey S Semeere; Naftali Busakhala; Jeffrey N Martin
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

Review 2.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

3.  Management of HIV associated Kaposi's sarcoma in Malawi.

Authors:  Yohannie Mlombe
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

4.  Imatinib for highly chemoresistant Kaposi sarcoma in a patient with long-term HIV control: a case report and literature review.

Authors:  W Cao; K Vyboh; B Routy; M Chababi-Atallah; B Lemire; J P Routy
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

5.  Is Kaposi's sarcoma occurring at higher CD4 cell counts over the course of the HIV epidemic?

Authors:  Nancy F Crum-Cianflone; Katherine Huppler Hullsiek; Anuradha Ganesan; Amy Weintrob; Jason F Okulicz; Brian K Agan
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

6.  Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.

Authors:  Sara Lodi; Marguerite Guiguet; Dominique Costagliola; Martin Fisher; Andrea de Luca; Kholoud Porter
Journal:  J Natl Cancer Inst       Date:  2010-05-04       Impact factor: 13.506

7.  Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.

Authors:  Owen Ngalamika; For Yue Tso; Salum Lidenge; Sody Munsaka; Danielle Shea; Charles Wood; John West
Journal:  PLoS One       Date:  2020-07-07       Impact factor: 3.240

8.  Consensus of the Brazilian Society of Infectious Diseases and Brazilian Society of Clinical Oncology on the management and treatment of Kaposi's sarcoma.

Authors:  Érico Arruda; Alexandre Andrade dos Anjos Jacome; Ana Luiza de Castro Conde Toscano; Anderson Arantes Silvestrini; André Santa Bárbara Rêgo; Evanius Garcia Wiermann; Geraldo Felicio da Cunha; Heloisa Ramos Lacerda de Melo; Karen Mirna Loro Morejón; Luciano Zubaran Goldani; Luiz Carlos Pereira; Mariliza Henrique Silva; Mauro Sergio Treistman; Mônica Cristina Toledo Pereira; Patricia Maria Bezerra Xavier Romero; Rafael Aron Schmerling; Rodrigo Antonio Vieira Guedes; Veridiana Pires de Camargo
Journal:  Braz J Infect Dis       Date:  2014-02-11       Impact factor: 3.257
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.